These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28237067)

  • 1. Utility of CEA and CA 15-3 measurements in non-purulent pleural exudates in the diagnosis of malignancy: A single-center experience.
    Porcel JM; Civit C; Esquerda A; Salud A; Bielsa S
    Arch Bronconeumol; 2017 Aug; 53(8):427-431. PubMed ID: 28237067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.
    Romero S; Fernández C; Arriero JM; Espasa A; Candela A; Martín C; Sánchez-Payá J
    Eur Respir J; 1996 Jan; 9(1):17-23. PubMed ID: 8834328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEA and CA 549 in serum and pleural fluid of patients with pleural effusion.
    Hernández L; Espasa A; Fernández C; Candela A; Martín C; Romero S
    Lung Cancer; 2002 Apr; 36(1):83-9. PubMed ID: 11891038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
    Gaspar MJ; De Miguel J; García Díaz JD; Díez M
    Anticancer Res; 2008; 28(5B):2947-52. PubMed ID: 19031938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
    Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
    Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
    Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
    Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion.
    Wagner IC; Guimarães MJ; da Silva LK; de Melo FM; Muniz MT
    J Bras Pneumol; 2007; 33(2):185-91. PubMed ID: 17724538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 10. The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion.
    Sthaneshwar P; Yap SF; Jayaram G
    Malays J Pathol; 2002 Jun; 24(1):53-8. PubMed ID: 16329556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F
    Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
    Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
    Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of CEA in pleural fluid for differential diagnosis of benign and malign pleural effusion.
    Radjenovic-Petkovic T; Pejcic T; Nastasijević-Borovac D; Rancic M; Radojkovic D; Radojkovic M; Djordjevic I
    Med Arh; 2009; 63(3):141-2. PubMed ID: 20088159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers.
    Fazli Khalaf F; Asadi Gharabaghi M; Balibegloo M; Davari H; Afshar S; Jahanbin B
    Int J Biol Markers; 2023 Jun; 38(2):81-88. PubMed ID: 36942429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
    Wang XF; Wu YH; Wang MS; Wang YS
    Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
    Porcel JM; Salud A; Vives M; Esquerda A; Rodríguez-Panadero F
    Clin Biochem; 2005 Nov; 38(11):1031-3. PubMed ID: 15925354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Accuracy of Combinations of Tumor Markers for Malignant Pleural Effusion: An Updated Meta-Analysis.
    Yang Y; Liu YL; Shi HZ
    Respiration; 2017; 94(1):62-69. PubMed ID: 28427079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cholesterol and soluble tumour markers CEA and syndecan-2 in pleural effusions in cases of inconclusive cytology.
    Gulyas M; Fillinger J; Kaposi AD; Molnar M
    J Clin Pathol; 2019 Aug; 72(8):529-535. PubMed ID: 31028099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
    Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
    Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4.
    Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
    Lung Cancer; 2003 Jun; 40(3):289-94. PubMed ID: 12781427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.